Loxo Oncology was founded in 2013.
Loxo Oncology was incorporated in the state of Delaware in May 2013.
281 Tresser Boulevard, 9th Floor Stamford, CT 06901 Phone: (203)-653-3880
You can view our Board of Directors by visiting the Board of Directors section of our website.
You can view our management team by visiting the Management section of our website.
Ernst & Young, LLP
Loxo Oncology is traded on the Nasdaq stock exchange under the symbol “LOXO”.
Loxo Oncology went public on August 1, 2014.
Shares can be purchased through a stockbroker of your choice.
Loxo Oncology does not offer a direct stock purchase plan.
Currently, Loxo Oncology does not offer a dividend or a dividend reinvestment program.
Loxo Oncology's transfer agent is American Stock Transfer and Trust Company, LLC (AST). You can find more information about how to contact AST by clicking here.
Please contact our transfer agent, American Stock Transfer, by clicking here. The company can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
You must send both your old and new addresses to our transfer agent, American Stock Transfer (click here to visit site), by U.S. mail. Each stockholder in question must sign the request for an address change.
Quarterly & Annual Reports and other investor materials are available under Financials & Filings of the Investors section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
You can view our recent press releases by visiting the Press Releases section of our website.
You can view information on our platform and programs by visiting the Pipeline section of our website.
For investor related questions, please send an email to email@example.com.
Please visit Contact Us and fill out our web form.